Osteoporosis.  2012 Aug;10(2):76-81.

A Case of Intractable Bisphosphonate-Related Osteonecrosis of the Jaw Treated with Teriparatide

Affiliations
  • 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. YUMIE@yuhs.ac
  • 2Department of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei University, Seoul, Korea.

Abstract

Bisphosphonates are the most widely used medications for treating high bone turnover osteoporosis, Paget's disease of bone, multiple myeloma and metastatic carcinomas, etc. However, a destructive complication of bisphosphonate-related osteonecrosis of the jaw (BRONJ) can occur. The treatments of BRONJ are challenging and the currently recommended managements for BRONJ are still controversial. Our case demonstrated that teriparatide can be a treatment of choice for intractable BRONJ, which had not been cured for 2 years even with the proper surgical treatment and withdrawal of bisphosphonates.

Keyword

Bisphosphonate; Bisphosphonate-related osteonecrosis of the jaw (BRONJ); Teriparatide

MeSH Terms

Bisphosphonate-Associated Osteonecrosis of the Jaw
Diphosphonates
Multiple Myeloma
Osteitis Deformans
Osteoporosis
Teriparatide
Diphosphonates
Teriparatide
Full Text Links
  • OST
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr